Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
Multidrug-resistant Gram-negative bacterial infections
2025 Standout
Nanoarchitectonics of in Situ Antibiotic-Releasing Acicular Nanozymes for Targeting and Inducing Cuproptosis-like Death to Eliminate Drug-Resistant Bacteria
2024 Standout
Works of Jüri Teras being referenced
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
2008
Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jüri Teras | 56 | 125 | 48 | 145 | 103 | 18 | 393 | |
| J. B. Gunnison | 42 | 95 | 20 | 79 | 120 | 20 | 443 | |
| H. Drugeon | 33 | 90 | 29 | 137 | 191 | 35 | 452 | |
| Yoko Takayama | 24 | 107 | 31 | 120 | 45 | 42 | 337 | |
| Alper Tünger | 57 | 113 | 12 | 102 | 61 | 37 | 407 | |
| B J McGrath | 39 | 114 | 12 | 136 | 157 | 10 | 340 | |
| P. J. Wilkinson | 15 | 99 | 30 | 90 | 135 | 15 | 340 | |
| Patricia Farrel | 50 | 172 | 7 | 117 | 66 | 15 | 434 | |
| R. Kohlmann | 27 | 93 | 11 | 127 | 50 | 21 | 417 | |
| R R Packer | 50 | 118 | 8 | 185 | 202 | 22 | 409 | |
| E. Diza | 35 | 94 | 15 | 120 | 39 | 23 | 438 |
All Works
Loading papers...